| Eastern Long Island Family Medicine Pc | |
|
100 S Jersey Ave Suite 14 East Setauket NY 11733-2034 | |
| (631) 751-3883 | |
| (631) 751-3909 |
| Full Name | Eastern Long Island Family Medicine Pc |
|---|---|
| Speciality | Family Medicine |
| Location | 100 S Jersey Ave, East Setauket, New York |
| Authorized Official Name and Position | Christopher Ng (PRESIDENT) |
| Authorized Official Contact | 6317513883 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Eastern Long Island Family Medicine Pc 100 S Jersey Ave Suite 14 East Setauket NY 11733-2034 Ph: (631) 751-3883 | Eastern Long Island Family Medicine Pc 100 S Jersey Ave Suite 14 East Setauket NY 11733-2034 Ph: (631) 751-3883 |
| NPI Number | 1003089640 |
|---|---|
| Provider Enumeration Date | 04/03/2008 |
| Last Update Date | 10/23/2013 |
| Medicare PECOS PAC ID | 6507779352 |
|---|---|
| Medicare Enrollment ID | O20031111000713 |
News Archive
The Environmental Protection Agency has designated January as National Radon Action Month. According to recent reports from the World Health Organization, radon gas is responsible for approximately 20,000 deaths in the U.S. and 100,000 deaths worldwide each year.
Arrowhead Research Corporation today announced publication in Proceedings of the National Academy of Sciences (PNAS) of a study using Nanotope's lead compound for cartilage regeneration. The study's authors, which include Nanotope co-founder Dr. Samuel Stupp, showed that Nanotope's bioactive nanofiber system promotes the growth of new cartilage in a rabbit model. The treatment is engineered to repair cartilage defects by working with an animal's own bone marrow stem cells to stimulate the production of new natural cartilage.
Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that its product candidate CRTX-067 is an ANDA filing for a generic 10 mg chlorpheniramine polistirex/8 mg hydrocodone polistirex suspension product that will be a generic substitute for the product currently sold under the Tussionex brand name by UCB, Inc.
According to a study of physicians' attitudes about pain drugs published in The Journal of Pain, negative physician attitudes about opioid medications are closely associated with lower rates of prescribing and more favorable attitudes are linked with higher prescribing levels.
BIOSAFE, Inc., a company that manufactures and sells a novel antimicrobial polymer, has announced that they are launching in specific markets outside the United States through a unique facemask treated with BIOSAFE(®). Crosstex' new BIOSAFE-treated Ultra Sensitive facemasks begin to reduce microorganisms such as MRSA, VRE, and Staph immediately upon contact, and have further proven to be effective against Influenza A strains such as seasonal flu and the novel H1N1 virus.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003089640 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 211195 (New York) | Primary |
| Provider Name | Christopher Ng |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1134127616 PECOS PAC ID: 3678486420 Enrollment ID: I20040109000878 |
News Archive
The Environmental Protection Agency has designated January as National Radon Action Month. According to recent reports from the World Health Organization, radon gas is responsible for approximately 20,000 deaths in the U.S. and 100,000 deaths worldwide each year.
Arrowhead Research Corporation today announced publication in Proceedings of the National Academy of Sciences (PNAS) of a study using Nanotope's lead compound for cartilage regeneration. The study's authors, which include Nanotope co-founder Dr. Samuel Stupp, showed that Nanotope's bioactive nanofiber system promotes the growth of new cartilage in a rabbit model. The treatment is engineered to repair cartilage defects by working with an animal's own bone marrow stem cells to stimulate the production of new natural cartilage.
Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that its product candidate CRTX-067 is an ANDA filing for a generic 10 mg chlorpheniramine polistirex/8 mg hydrocodone polistirex suspension product that will be a generic substitute for the product currently sold under the Tussionex brand name by UCB, Inc.
According to a study of physicians' attitudes about pain drugs published in The Journal of Pain, negative physician attitudes about opioid medications are closely associated with lower rates of prescribing and more favorable attitudes are linked with higher prescribing levels.
BIOSAFE, Inc., a company that manufactures and sells a novel antimicrobial polymer, has announced that they are launching in specific markets outside the United States through a unique facemask treated with BIOSAFE(®). Crosstex' new BIOSAFE-treated Ultra Sensitive facemasks begin to reduce microorganisms such as MRSA, VRE, and Staph immediately upon contact, and have further proven to be effective against Influenza A strains such as seasonal flu and the novel H1N1 virus.
› Verified 4 days ago
| Provider Name | Catheryne Leon |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1164806535 PECOS PAC ID: 3476897588 Enrollment ID: I20181130000357 |
News Archive
The Environmental Protection Agency has designated January as National Radon Action Month. According to recent reports from the World Health Organization, radon gas is responsible for approximately 20,000 deaths in the U.S. and 100,000 deaths worldwide each year.
Arrowhead Research Corporation today announced publication in Proceedings of the National Academy of Sciences (PNAS) of a study using Nanotope's lead compound for cartilage regeneration. The study's authors, which include Nanotope co-founder Dr. Samuel Stupp, showed that Nanotope's bioactive nanofiber system promotes the growth of new cartilage in a rabbit model. The treatment is engineered to repair cartilage defects by working with an animal's own bone marrow stem cells to stimulate the production of new natural cartilage.
Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that its product candidate CRTX-067 is an ANDA filing for a generic 10 mg chlorpheniramine polistirex/8 mg hydrocodone polistirex suspension product that will be a generic substitute for the product currently sold under the Tussionex brand name by UCB, Inc.
According to a study of physicians' attitudes about pain drugs published in The Journal of Pain, negative physician attitudes about opioid medications are closely associated with lower rates of prescribing and more favorable attitudes are linked with higher prescribing levels.
BIOSAFE, Inc., a company that manufactures and sells a novel antimicrobial polymer, has announced that they are launching in specific markets outside the United States through a unique facemask treated with BIOSAFE(®). Crosstex' new BIOSAFE-treated Ultra Sensitive facemasks begin to reduce microorganisms such as MRSA, VRE, and Staph immediately upon contact, and have further proven to be effective against Influenza A strains such as seasonal flu and the novel H1N1 virus.
› Verified 4 days ago
| Provider Name | Judith M Magloczki |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1801240064 PECOS PAC ID: 2264769868 Enrollment ID: I20200722003191 |
News Archive
The Environmental Protection Agency has designated January as National Radon Action Month. According to recent reports from the World Health Organization, radon gas is responsible for approximately 20,000 deaths in the U.S. and 100,000 deaths worldwide each year.
Arrowhead Research Corporation today announced publication in Proceedings of the National Academy of Sciences (PNAS) of a study using Nanotope's lead compound for cartilage regeneration. The study's authors, which include Nanotope co-founder Dr. Samuel Stupp, showed that Nanotope's bioactive nanofiber system promotes the growth of new cartilage in a rabbit model. The treatment is engineered to repair cartilage defects by working with an animal's own bone marrow stem cells to stimulate the production of new natural cartilage.
Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that its product candidate CRTX-067 is an ANDA filing for a generic 10 mg chlorpheniramine polistirex/8 mg hydrocodone polistirex suspension product that will be a generic substitute for the product currently sold under the Tussionex brand name by UCB, Inc.
According to a study of physicians' attitudes about pain drugs published in The Journal of Pain, negative physician attitudes about opioid medications are closely associated with lower rates of prescribing and more favorable attitudes are linked with higher prescribing levels.
BIOSAFE, Inc., a company that manufactures and sells a novel antimicrobial polymer, has announced that they are launching in specific markets outside the United States through a unique facemask treated with BIOSAFE(®). Crosstex' new BIOSAFE-treated Ultra Sensitive facemasks begin to reduce microorganisms such as MRSA, VRE, and Staph immediately upon contact, and have further proven to be effective against Influenza A strains such as seasonal flu and the novel H1N1 virus.
› Verified 4 days ago
News Archive
The Environmental Protection Agency has designated January as National Radon Action Month. According to recent reports from the World Health Organization, radon gas is responsible for approximately 20,000 deaths in the U.S. and 100,000 deaths worldwide each year.
Arrowhead Research Corporation today announced publication in Proceedings of the National Academy of Sciences (PNAS) of a study using Nanotope's lead compound for cartilage regeneration. The study's authors, which include Nanotope co-founder Dr. Samuel Stupp, showed that Nanotope's bioactive nanofiber system promotes the growth of new cartilage in a rabbit model. The treatment is engineered to repair cartilage defects by working with an animal's own bone marrow stem cells to stimulate the production of new natural cartilage.
Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that its product candidate CRTX-067 is an ANDA filing for a generic 10 mg chlorpheniramine polistirex/8 mg hydrocodone polistirex suspension product that will be a generic substitute for the product currently sold under the Tussionex brand name by UCB, Inc.
According to a study of physicians' attitudes about pain drugs published in The Journal of Pain, negative physician attitudes about opioid medications are closely associated with lower rates of prescribing and more favorable attitudes are linked with higher prescribing levels.
BIOSAFE, Inc., a company that manufactures and sells a novel antimicrobial polymer, has announced that they are launching in specific markets outside the United States through a unique facemask treated with BIOSAFE(®). Crosstex' new BIOSAFE-treated Ultra Sensitive facemasks begin to reduce microorganisms such as MRSA, VRE, and Staph immediately upon contact, and have further proven to be effective against Influenza A strains such as seasonal flu and the novel H1N1 virus.
› Verified 4 days ago
L&l Holistic Healing, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6 S Jersey Ave, East Setauket, NY 11733 Phone: 516-605-4868 | |
Long Island Digestive Disease Consultants, Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3400 Nesconset Hwy, Ste 101, East Setauket, NY 11733 Phone: 631-751-8700 Fax: 631-751-5971 | |
North Suffolk Family Medical Care Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4 Technology Dr, Suite 210, East Setauket, NY 11733 Phone: 631-331-1506 Fax: 631-331-1705 | |
Digestive Disease Care, Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 235 N Belle Mead Rd, East Setauket, NY 11733 Phone: 631-450-1500 Fax: 347-236-3163 | |
Unique You Medical Wellness Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8 Technology Drive, Suite 104, East Setauket, NY 11733 Phone: 516-704-7447 | |
Setauket Medical, Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4 Technology Dr, Suite 220, East Setauket, NY 11733 Phone: 631-964-9581 Fax: 631-476-9298 |